Literature DB >> 10568831

Expression of angiostatic factors in colorectal cancer.

Y Yoshida1, Y Oshika, Y Fukushima, T Tokunaga, H Hatanaka, H Kijima, H Yamazaki, Y Ueyama, N Tamaoki, S Miura, M Nakamura.   

Abstract

Angiogenesis plays an important role in growth and proliferation of cancer. Various angiogenic and angiostatic factors regulate angiogenesis. We examined expression of genes encoding various angiostatic factors: thrombospondin 1 (TSP1), thrombospondin 2 (TSP2), brain-specific angiogenesis inhibitor 1 (BAI1) and angiopoietin 2 (AGP2) in 62 colorectal cancers and 40 samples of extraneoplastic colon mucosa. The expression of the angiostatic factors TSP2 and AGP2 were significantly increased in the cancerous mucosa as compared to these in extraneoplastic mucosa (o2 test; p<0. 0001, and Fisher's exact test; p<0.0001), while the increase in TSP1 expression was not significant. BAI1 expression was slightly decreased in the cancer tissue. These results suggested that specific types of angiostatic factors might have protective roles against cancer cell proliferation via dormancy due to hyponutrition caused by decreased vascularity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10568831     DOI: 10.3892/ijo.15.6.1221

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  20 in total

Review 1.  Antiangiogenic therapy in human gastrointestinal malignancies.

Authors:  J Heidemann; D G Binion; W Domschke; T Kucharzik
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

Review 2.  The Emerging Role of Adhesion GPCRs in Cancer.

Authors:  Abanoub A Gad; Nariman Balenga
Journal:  ACS Pharmacol Transl Sci       Date:  2020-01-13

Review 3.  Adhesion GPCRs in Tumorigenesis.

Authors:  Gabriela Aust; Dan Zhu; Erwin G Van Meir; Lei Xu
Journal:  Handb Exp Pharmacol       Date:  2016

Review 4.  Emerging roles for the BAI1 protein family in the regulation of phagocytosis, synaptogenesis, neurovasculature, and tumor development.

Authors:  Sarah M Cork; Erwin G Van Meir
Journal:  J Mol Med (Berl)       Date:  2011-04-21       Impact factor: 4.599

5.  Phase I Study of MEDI3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined with Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid Tumors.

Authors:  David M Hyman; Naiyer Rizvi; Ronald Natale; Deborah K Armstrong; Michael Birrer; Lawrence Recht; Efrat Dotan; Vicky Makker; Thomas Kaley; Denison Kuruvilla; Matthew Gribbin; Jennifer McDevitt; Dominic W Lai; Mohammed Dar
Journal:  Clin Cancer Res       Date:  2018-03-20       Impact factor: 12.531

Review 6.  Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.

Authors:  M T M van Jaarsveld; J M Houthuijzen; E E Voest
Journal:  Oncogene       Date:  2015-12-07       Impact factor: 9.867

Review 7.  Thrombospondin-1: a physiological regulator of nitric oxide signaling.

Authors:  J S Isenberg; W A Frazier; D D Roberts
Journal:  Cell Mol Life Sci       Date:  2008-03       Impact factor: 9.261

8.  Angiopoietin-2 expression is correlated with angiogenesis and overall survival in oral squamous cell carcinoma.

Authors:  Chao Li; Chang-jin Sun; Jin-chuan Fan; Ning Geng; Chun-hua Li; Jian Liao; Kun Mi; Gui-quan Zhu; Hong Ma; Yu-feng Song; Ya-ling Tang; Yu Chen
Journal:  Med Oncol       Date:  2013-05-07       Impact factor: 3.064

9.  Intestinal resection induces angiogenesis within adapting intestinal villi.

Authors:  Colin A Martin; Erin E Perrone; Shannon W Longshore; Paul Toste; Kathryn Bitter; Rajalakshmi Nair; Jun Guo; Christopher R Erwin; Brad W Warner
Journal:  J Pediatr Surg       Date:  2009-06       Impact factor: 2.545

Review 10.  Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies.

Authors:  Jeff S Isenberg; Gema Martin-Manso; Justin B Maxhimer; David D Roberts
Journal:  Nat Rev Cancer       Date:  2009-02-05       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.